Discontinued Operations

6 Months Ended

Mar. 31, 2014

Discontinued Operations [Abstract]

Discontinued Operations [Text Block]

Note 2. Discontinued Operations

In May 2013, the Company completed the divestiture of its packaging and clinical trials services business, AndersonBrecon (“AB”),andAmerisourceBergen Canada Corporation (“ABCC”).The Company has classified AB and ABCC's operating results, net of tax, as discontinued operations in the accompanying consolidated statements of operations for all periods presented. Prior to being classified within discontinued operations, AB was included in Other and ABCC was included in Pharmaceutical Distribution for segment reporting. AB and ABCC's revenue and loss before income taxes were as follows:

	Three months ended March 31,					Six months ended March 31,
(in thousands)		2014		2013	2014		2013
Revenue	$	-	$	441,277	$	-	$	915,508
Loss before income taxes	$	-	$	(154,561)	$	(7,546)	$	(156,613)

The loss before income taxes in the six months ended March 31, 2014 includes the impact of a final purchase price working capital adjustment related to the divestiture of ABCC. The loss before income taxes in the three and six months ended March 31, 2013 includes a goodwill impairment charge of $26.9 million and an estimated $134.8 million loss on the sale of ABCC.